Marlowe has released a strong set of H1/22E results, with 15% organic revenue growth (or 8% if you adjust for the impact of Covid-19 on prior year comps), divisional Adj EBITDA margins up 300bps YoY to 17.8%, Marlowe's high-margin GRC division accounting for over half of H1/22E group Adj EBITDA. Boosted by recent acquisitions and organic growth, Marlowe's high-margin GRC division now accounts for more than half of the group's total Adj EBITDA. Management recently confirmed it was trading ahead ....
01 Dec 2021
Cenkos: Marlowe Plc -- Trading ahead of expectations for FY22E
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Marlowe Plc -- Trading ahead of expectations for FY22E
Marlowe Plc (MRL:LON) | 508 0 0.0% | Mkt Cap: 491.8m
- Published:
01 Dec 2021 -
Author:
Peter Renton -
Pages:
8
Marlowe has released a strong set of H1/22E results, with 15% organic revenue growth (or 8% if you adjust for the impact of Covid-19 on prior year comps), divisional Adj EBITDA margins up 300bps YoY to 17.8%, Marlowe's high-margin GRC division accounting for over half of H1/22E group Adj EBITDA. Boosted by recent acquisitions and organic growth, Marlowe's high-margin GRC division now accounts for more than half of the group's total Adj EBITDA. Management recently confirmed it was trading ahead ....